BETAHISTINE RMB betahistine dihydrochloride 24 mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

betahistine dihydrochloride, Quantity: 24 mg

Commercializzato da:

Southern XP IP Pty Ltd

INN (Nome Internazionale):

betahistine dihydrochloride

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil

Via di somministrazione:

Oral

Confezione:

25

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.

Dettagli prodotto:

Visual Identification: White flat tablets with bevelled edges and a break line on one side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2017-03-02